https://de.marketscreener.com/kurs/aktie/HALOZYME-THERAPEUTICS-INC-50245/news/Halozyme-gibt-bekannt-dass-Takeda-die-FDA-Zulassung-fur-Hyqvia-in-Kombination-mit-Enhanze-als-45752248/?utm_source=telegram&utm_medium=social&utm_campaign=share